Home › Funds › Hosking Partners LLP › ELV

Hosking Partners LLP position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Hosking Partners LLP reported holding 140,427 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$54.6M, representing 1.94% of its reported portfolio and ranking #14 among its reported holdings. Hosking Partners LLP has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)140.43K sh
Reported value held$54.60M
Portfolio Weight1.94%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hosking Partners LLP's ELV position evolved

Hosking Partners LLP first disclosed a stake in ELV in Q3 2023 at 120,737 shares (US$52.6M). The position peaked in Q1 2024 at 112,414 shares, worth US$58.3M. Across 13 filings, Hosking Partners LLP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 140,427 shares valued at US$54.6M — a reduction of -9,584 shares quarter over quarter.. Notable position changes include a 85% increase in Q3 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 120.74K $52.57M New
Q4 2023 112.75K $53.17M Reduce
Q1 2024 112.41K $58.29M Hold
Q2 2024 103.49K $56.08M Reduce
Q3 2024 88.25K $45.89M Reduce
Q4 2024 78.24K $28.86M Reduce
Q1 2025 77.55K $33.73M Reduce
Q2 2025 77.08K $29.98M Reduce
Q3 2025 142.38K $46.01M Add
Q4 2025 144.55K $50.67M Add
Q1 2026 152.44K $44.63M Add
Q2 2026 150.01K $58.01M Reduce
Q3 2026 140.43K $54.60M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Hosking Partners LLP held ELV?

Hosking Partners LLP has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Hosking Partners LLP's current position in ELV?

As of Q3 2026, Hosking Partners LLP holds 140.43K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $54.60M, representing 1.94% of its reported portfolio and ranking #14.

Has Hosking Partners LLP been buying or selling ELV?

In the latest 13F filing (Q3 2026), Hosking Partners LLP reduced its position in ELV. The position peaked in Q1 2024 at 112.41K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.